BTLA-expressing CD11c antigen presenting cells in patients with active tuberculosis exhibit low capacity to stimulate T cell proliferation
Authors:
- 1 January 2017
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 311, 28-35
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273237, 81570009)
- Natural Science Foundation of Guangdong Province (2015A030313513)
- Science and Technology Innovation Fund (STIF201110)
This publication has 32 references indexed in Scilit:
- BTLA Interaction with HVEM Expressed on CD8+ T Cells Promotes Survival and Memory Generation in Response to a Bacterial InfectionPLOS ONE, 2013
- CD8 T Cell Memory to a Viral Pathogen Requires Trans Cosignaling between HVEM and BTLAPLOS ONE, 2013
- Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathwayBlood, 2011
- Human Langerhans cells induce distinct IL-22-producing CD4 + T cells lacking IL-17 productionProceedings of the National Academy of Sciences, 2009
- B and T Lymphocyte Attenuator Tempers Early Infection ImmunityThe Journal of Immunology, 2009
- Cell-Mediated Immune Responses in TuberculosisAnnual Review of Immunology, 2009
- An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platformJournal of Immunological Methods, 2009
- Development of autoimmune hepatitis–like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuatorArthritis & Rheumatism, 2008
- A crucial role for HVEM and BTLA in preventing intestinal inflammationJournal of Experimental Medicine, 2008
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003